Show simple item record

dc.contributor.authorMeyer, Retsina M.
dc.contributor.authorBurgos-Robles, Anthony Noel
dc.contributor.authorLiu, Elizabeth
dc.contributor.authordos Santos Correia, Susana Maria
dc.contributor.authorGoosens, Ki Ann
dc.date.accessioned2016-05-09T13:02:36Z
dc.date.available2016-05-09T13:02:36Z
dc.date.issued2013-10
dc.date.submitted2013-08
dc.identifier.issn1359-4184
dc.identifier.issn1476-5578
dc.identifier.urihttp://hdl.handle.net/1721.1/102419
dc.description.abstractHormones in the hypothalamus–pituitary–adrenal (HPA) axis mediate many of the bodily responses to stressors, yet there is no clear relationship between the levels of these hormones and stress-associated mental illnesses such as posttraumatic stress disorder (PTSD). Therefore, other hormones are likely to be involved in this effect of stress. Here we used a rodent model of PTSD in which rats repeatedly exposed to a stressor display heightened fear learning following auditory Pavlovian fear conditioning. Our results show that stress-related increases in circulating ghrelin, a peptide hormone, are necessary and sufficient for stress-associated vulnerability to exacerbated fear learning and these actions of ghrelin occur in the amygdala. Importantly, these actions are also independent of the classic HPA stress axis. Repeated systemic administration of a ghrelin receptor agonist enhanced fear memory but did not increase either corticotropin-releasing factor (CRF) or corticosterone. Repeated intraamygdala infusion of a ghrelin receptor agonist produced a similar enhancement of fear memory. Ghrelin receptor antagonism during repeated stress abolished stress-related enhancement of fear memory without blunting stress-induced corticosterone release. We also examined links between ghrelin and growth hormone (GH), a major downstream effector of the ghrelin receptor. GH protein was upregulated in the amygdala following chronic stress, and its release from amygdala neurons was enhanced by ghrelin receptor stimulation. Virus-mediated overexpression of GH in the amygdala was also sufficient to increase fear. Finally, virus-mediated overexpression of a GH receptor antagonist was sufficient to block the fear-enhancing effects of repeated ghrelin receptor stimulation. Thus, ghrelin requires GH in the amygdala to exert fear-enhancing effects. These results suggest that ghrelin mediates a novel branch of the stress response and highlight a previously unrecognized role for ghrelin and growth hormone in maladaptive changes following prolonged stress.en_US
dc.description.sponsorshipMassachusetts Institute of Technology. Undergraduate Research Opportunities Programen_US
dc.description.sponsorshipHugh Hampton Young Memorial Fellowshipen_US
dc.description.sponsorshipSchoemaker Fellowshipen_US
dc.description.sponsorshipSingleton Presidential Funden_US
dc.description.sponsorshipJames R. Killian Fellowshipen_US
dc.description.sponsorshipNational Institute of Mental Health (U.S.) (R01 MH084966)en_US
dc.description.sponsorshipUnited States. Army Research Officeen_US
dc.description.sponsorshipUnited States. Defense Advanced Research Projects Agency (Grant W911NF-10-1-0059)en_US
dc.language.isoen_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/mp.2013.135en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleA ghrelin–growth hormone axis drives stress-induced vulnerability to enhanced fearen_US
dc.typeArticleen_US
dc.identifier.citationMeyer, R M, A Burgos-Robles, E Liu, S S Correia, and K A Goosens. “A Ghrelin–growth Hormone Axis Drives Stress-Induced Vulnerability to Enhanced Fear.” Mol Psychiatry 19, no. 12 (October 15, 2013): 1284–1294.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.departmentPicower Institute for Learning and Memoryen_US
dc.contributor.mitauthorMeyer, Retsina M.en_US
dc.contributor.mitauthorBurgos-Robles, Anthony Noelen_US
dc.contributor.mitauthorLiu, Elizabethen_US
dc.contributor.mitauthordos Santos Correia, Susana Mariaen_US
dc.contributor.mitauthorGoosens, Ki Annen_US
dc.relation.journalMolecular Psychiatryen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsMeyer, R M; Burgos-Robles, A; Liu, E; Correia, S S; Goosens, K Aen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-2570-4587
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record